Abstract for Annual meeting held in Queenstown, New Zealand 2-4 September 2019.  The abstract will be submitted to the conference organisers and if successful, the studies will be presented as a poster.

This is a re-submission of the abstract submitted to ROI 001364, which was not approved due to concerns raised by Mark Aspin about the content of a poster possibly revealing commercially sensitive material. (Marks's comments in ROI 001364 - In principle this could be OK but I would like to understand what is known or likely to be revealed by this poster with respect to the binding mechanisms of the antibodies - This could be very important for commercial application and I would want to be absolutely certain that we are not revealing these mechanisms inadvertently. Our approval will be conditional on us be assured of this)

We replied to Mark (email 10/7/2019)
Would it be acceptable for the abstract to  be submitted with the understanding, that we will start work on a poster right away, taking care that no information on antibody binding that could be important for commercial application is included.  We would aim to submit the draft poster into the NZAGRC ROI  well before the conference date to ensure there is plenty of time for review and make any changes if required.  In the worst case scenario, we would not present the poster.
 
Mark agreed that this approach would be okay.

